Screener
BioCryst Pharmaceuticals BCRX Stock Issued During Period Value Employee Stock Purchase Plan
Stock Issued During Period Value Employee Stock Purchase Plan at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
FAQ
- What is BioCryst Pharmaceuticals's stock issued during period value employee stock purchase plan?
- BioCryst Pharmaceuticals (BCRX) reported stock issued during period value employee stock purchase plan of $1.11M in Q1 2026.
- How has BioCryst Pharmaceuticals's stock issued during period value employee stock purchase plan changed year-over-year?
- BioCryst Pharmaceuticals's stock issued during period value employee stock purchase plan decreased by 8.5% year-over-year, from $1.22M to $1.11M.
- What does stock issued during period value employee stock purchase plan mean?
- Stock Issued During Period Value Employee Stock Purchase Plan as reported by BioCryst Pharmaceuticals Inc.
Ask your AI about BioCryst Pharmaceuticals's stock issued during period value employee stock purchase plan.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude